Drugs / IGFBP-3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00673309 | Jul 2000 → Apr 2011 | — | The University of Texas Medical Branch, Galveston | Completed | No outcome recorded |
Press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2007-06-26 | Insmed Incorporated | Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants insmed.com ↗ |
| 2002-11-04 | Insmed Incorporated | Insmed Presents IGFBP-3 Anti-Cancer Data at the International Symposium on the Functional Role of IGFBP's insmed.com ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IGFBP-3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00673309 ↗ |